Harvard Apparatus Regenerative Technology (Nasdaq: HART), a biotechnology company developing bioengineered organ implants for life-threatening conditions of the esophagus, trachea and bronchus, announced today that Laura Mondano has joined the company as Vice President of Regulatory Affairs, a new position at HART
http://www.prnewswire.com/news-releases/hart-appoints-laura-mondano-as-vice-president-of-regulatory-affairs-to-lead-harts-2016-ind-submission-for-its-bioengineered-organ-implant-solutions-300229895.html
HART Appoints Laura Mondano as Vice President of Regulatory Affairs To Lead HART's 2016 IND Submission For its Bioengineered Organ Implant Solutions